Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vitargent (International) Biotechnology

Vitargent (International) Biotechnology
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
4 INVESTORS
Description

Provider of biotechnology and testing services. The company's biotechnology and testing services develops transgenic medaka and zebrafish fish embryo for conducting toxic laboratory tests, enabling industries such as cosmetics, skincare, food and beverage conglomerate to safeguard their products against harmful chemicals.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
  • Unit 203, 16 West
  • Number 12 Science Park West Avenue
  • Shatin
  • Hong Kong

+852 2393 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vitargent (International) Biotechnology’s full profile, request a free trial.

Vitargent (International) Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 26-May-2016 Completed Generating Revenue
2. Early Stage VC (Series A) 20-Jan-2015 Completed Startup
1. Accelerator/Incubator 01-Jan-2010 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vitargent (International) Biotechnology Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eurofins Scientific Corporation Luxembourg, Luxembourg 00000 00000 000000000 00000
0000000 Venture Capital-Backed Rīga, Latvia 0 00000 0000000000 00000
0000000 Corporate Backed or Acquired Princeton, NJ 00000 000000&0
000 00000000 Formerly PE-Backed Newark, DE 0000 000000000 00
00000000000000 000 Private Equity-Backed Wilmington, NC 00000 00000 0000000 0000 00000
To view this company’s complete list of competitors, request access »

Vitargent (International) Biotechnology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
NFLS - Pivotal Venture Capital Minority 000 0000 000000 0
Crossgate Advisors Venture Capital Minority 000 0000 000000 0
WI Harper Group Venture Capital Minority 000 0000 000000 0
Hong Kong Science and Technology Parks Accelerator/Incubator 000 0000 000000 0

Vitargent (International) Biotechnology Executive Team (5)

Name Title Board
Seat
Contact
Info
Jimmy Tao Chief Executive Officer
Xueping Chen Ph.D Co-Founder, Chief Technology Officer & Director
Winston Wei Chief Marketing Officer
Eric Chen Co-Founder, Chief Commercial Officer & Director
Jeffrey Cheung Co-Founder, Chief Financial Officer & Director, Corporate Service

Vitargent (International) Biotechnology Board Members (1)

Name Representing Role Since Contact
Info
Peter Liu WI Harper Group Chairman 000 0000